These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9541692)

  • 21. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
    Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
    Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of pAKT and CD44v6 overexpression with breast cancer.
    Yu P; Zhou L; Ke W; Li K
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1283-92. PubMed ID: 20157733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].
    Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A
    Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44V6 expression in human colorectal carcinoma.
    Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
    Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of CD44 isoform expression in endometrial cancer.
    Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
    Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of CD44 splice variants in human stage III cervical cancer.
    Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
    Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
    Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM
    Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
    Jiang H; Zhao W; Shao W
    Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of CD44 variant 6 in laryngeal epidermoid carcinomas.
    Güler G; Saraç S; Uner A; Karabulut E; Ayhan A; Hiroshi O
    Arch Otolaryngol Head Neck Surg; 2002 Apr; 128(4):393-7. PubMed ID: 11926913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of CD44s, CD44v3 and CD44v6 in breast cancer.
    Wu XJ; Li XD; Zhang H; Zhang X; Ning ZH; Yin YM; Tian Y
    J Int Med Res; 2015 Apr; 43(2):173-9. PubMed ID: 25571897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies.
    Fang M; Wu J; Lai X; Ai H; Tao Y; Zhu B; Huang L
    Cell Physiol Biochem; 2016; 40(3-4):567-578. PubMed ID: 27889771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
    Spafford MF; Koeppe J; Pan Z; Archer PG; Meyers AD; Franklin WA
    Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):627-32. PubMed ID: 8639294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
    Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
    Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD44V6 in gastric carcinoma: a marker of tumor progression.
    Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
    Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
    Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44v6 expression is related to progression in renal epithelial tumours.
    de Alava E; Panizo A; Sola I; Rodríguez-Rubio FI; Pardo-Mindán FJ
    Histopathology; 1998 Jul; 33(1):39-45. PubMed ID: 9726047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD44 loss in gastric stromal tumors as a prognostic marker.
    Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
    Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. A comparative study between nodal and cutaneous lymphomas.
    Dommann SN; Ziegler T; Dommann-Schener CC; Meyer J; Panizzon R; Burg G
    J Cutan Pathol; 1995 Oct; 22(5):407-12. PubMed ID: 8594072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma.
    Bartakova A; Michalova K; Presl J; Vlasak P; Kostun J; Bouda J
    J Obstet Gynaecol; 2018 Jan; 38(1):110-114. PubMed ID: 28816557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.